Vpriv
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. VPRIV CMI V2 Velaglucerase alfa ghu Consumer …
Home » Medications »
Rozlytrek
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. ROCROZLY10720 This medicine is subject to additional …
FDA Approves Kineret (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)
WALTHAM, Mass., Dec. 22, 2020 (GLOBE NEWSWIRE) — Sobi™, an international biopharmaceutical company dedicated to rare diseases, announced that the …
FDA Approves Gemtesa
FDA Approves Gemtesa (vibegron) Tablets for the Treatment of Patients with Overactive Bladder (OAB) IRVINE, Calif. & BASEL, Switzerland–(BUSINESS WIRE)–Dec. …
FDA Approves Genentech’s Ocrevus (ocrelizumab) Shorter 2-Hour Infusion for Relapsing and Primary Progressive Multiple Sclerosis
South San Francisco, CA — December 14, 2020 — Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
GSK Presents Phase 2b Data on Linerixibat for the Treatment of Cholestatic Pruritus in Primary Biliary Cholangitis (PBC)
13 November 2020 — GlaxoSmithKline plc (GSK) today announced further progression in its R&D pipeline with presentation of data for …
FDA Approves Eysuvis
FDA Approves Eysuvis (loteprednol etabonate) Ophthalmic Suspension for the Short-Term Treatment of the Signs and Symptoms of Dry Eye Disease …
FDA Grants Priority Review and EMA Accepts Regulatory Submission for Pfizer’s Abrocitinib, an Oral Once-Daily JAK1 Inhibitor, for Patients 12 and Up with Moderate to Severe Atopic Dermatitis
NEW YORK–(BUSINESS WIRE) October 27, 2020 — Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration …
Moderna Announces Initiation of Rolling Submission to Health Canada for mRNA Vaccine Against COVID-19 (mRNA-1273)
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Oct. 13, 2020– Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create …
Lilly Announces Arrangement for Supply of Potential COVID-19 Antibody Therapy for Low- and Middle-Income Countries
INDIANAPOLIS, Oct. 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) and the Bill & Melinda Gates Foundation, as part of …
FDA Approves Detectnet
FDA Approves Detectnet (copper Cu 64 dotatate injection) Positron Emission Tomography (PET) Agent Houston, TX and St. Louis, MO, Sept. …
Current treatment for fungal meningitis is fueling drug resistance
A common first-line treatment approach for cryptococcal meningitis in low-income countries is being compromised by the emergence of drug resistance, …
Breast and kidney cancer drugs approved on NHS Scotland
Two new cancer treatment options have been accepted for use in Scotland for some patients living with breast and kidney …
Gene therapy: Development of new DNA transporters
Scientists at the Institute of Pharmacy at Martin Luther University Halle-Wittenberg (MLU) have developed new delivery vehicles for future gene …
Estuarine waters hold promise in global pain-relief hunt
The worldwide search for an opioid alternative has made a leap forward—with a scientific discovery in an Australian fungus indicating …
Ligelizumab safely, effectively treats hives
(HealthDay)—Ligelizumab appears to be a safe and effective treatment option for chronic spontaneous urticaria, according to a study published in …
France forgets own golden age of medical marijuana
This past summer, the French food and drug office, the Agence Nationale de Sécurité du Médicament, greenlighted limited medical cannabis …
A Purdue bankruptcy would make opioids cases even messier
State and local governments have sought billions of dollars from Purdue Pharma as a way to hold the company and …